ConductScience.org, home

Paper55838

Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis.

Knodell RG and 3 others. Lancet, 1976. Cited by 164 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Papers, record 55838. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55838

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
164
iCite
Relative citation ratio, by iCite
6.36
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Knodell RGR G
2Conrad MEM E
3Ginsberg ALA L
4Bell CJC J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HepatitisMajor topic
Hepatitis BMajor topic
Transfusion ReactionMajor topic
gamma-GlobulinsMajor topic
Adult
Child
Child, Preschool
Follow-Up Studies
Hepatitis B Antibodies
Hepatitis B Antigens
Hepatitis B virus
Humans
Jaundice
Placebos

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.

PMIDTitleJournalYearIn PapersSource
40573943Broadly Neutralizing Antibody Characteristics in Hepatitis C Virus Infection and Implications for Vaccine Design.Vaccines (Basel)2025https://conductscience.org/library/papers/40573943PubMed
24797372Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors.Transfusion2014https://conductscience.org/library/papers/24797372PubMed
22952447Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.PLoS Pathog2012https://conductscience.org/library/papers/22952447PubMed
22163337Neutralizing antibody response to hepatitis C virus.Viruses2011https://conductscience.org/library/papers/22163337PubMed
21917891Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus.J Infect Dis2011https://conductscience.org/library/papers/21917891PubMed
21034775Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid.J Virol Methods2011https://conductscience.org/library/papers/21034775PubMed
19564925HCV antibody response and genotype distribution in different areas and races of China.Int J Biol Sci2009https://conductscience.org/library/papers/19564925PubMed
19321602Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.J Virol2009https://conductscience.org/library/papers/19321602PubMed
18749799Internal medicine: non-a, non-B hepatitis.West J Med1985https://conductscience.org/library/papers/18749799PubMed
18272755Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.J Gen Virol2008https://conductscience.org/library/papers/18272755PubMed
17977972Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus.J Virol2008https://conductscience.org/library/papers/17977972PubMed
15136748Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15136748PubMed
12857782Managing occupational risks for hepatitis C transmission in the health care setting.Clin Microbiol Rev2003https://conductscience.org/library/papers/12857782PubMed
11023960Passive immunity in prevention and treatment of infectious diseases.Clin Microbiol Rev2000https://conductscience.org/library/papers/11023960PubMed
10885983Risk and management of blood-borne infections in health care workers.Clin Microbiol Rev2000https://conductscience.org/library/papers/10885983PubMed
6416439Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6416439PubMed
6407830Post-transfusion hepatitis and its association with pooled clotting factors.Eur J Clin Microbiol1983https://conductscience.org/library/papers/6407830PubMed
3146376Homologous blood use and conservation techniques for cardiac surgery in the United Kingdom.BMJ1988https://conductscience.org/library/papers/3146376PubMed
341538Antiviral therapy.Yale J Biol Med1977https://conductscience.org/library/papers/341538PubMed
76494Non-A non-B hepatitis.Br Med J1978https://conductscience.org/library/papers/76494PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55838

GET https://conductscience.org/api/papers/v1/55838/authors